Your browser doesn't support javascript.
loading
Therapeutic Gene Editing Safety and Specificity.
Lux, Christopher T; Scharenberg, Andrew M.
Afiliação
  • Lux CT; Department of Pediatrics, Cancer and Blood Disorders Center, Seattle Children's Hospital, 4800 Sand Point Way NE, Seattle, WA 98105, USA.
  • Scharenberg AM; Department of Pediatrics, Seattle Children's Hospital, 4800 Sand Point Way NE, Seattle, WA 98105, USA; Department of Immunology, Seattle Children's Hospital, 4800 Sand Point Way NE, Seattle, WA 98105, USA. Electronic address: Christopher.Lux@seattlechildrens.org.
Hematol Oncol Clin North Am ; 31(5): 787-795, 2017 10.
Article em En | MEDLINE | ID: mdl-28895847
ABSTRACT
Therapeutic gene editing is significant for medical advancement. Safety is intricately linked to the specificity of the editing tools used to cut at precise genomic targets. Improvements can be achieved by thoughtful design of nucleases and repair templates, analysis of off-target editing, and careful utilization of viral vectors. Advancements in DNA repair mechanisms and development of new generations of tools improve targeting of specific sequences while minimizing risks. It is important to plot a safe course for future clinical trials. This article reviews safety and specificity for therapeutic gene editing to spur dialogue and advancement.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Edição de Genes / Vetores Genéticos Limite: Animals / Humans Idioma: En Revista: Hematol Oncol Clin North Am Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Edição de Genes / Vetores Genéticos Limite: Animals / Humans Idioma: En Revista: Hematol Oncol Clin North Am Ano de publicação: 2017 Tipo de documento: Article